18F-FDOPA PET and PET/CT accurately localize pheochromocytomas

F Imani, VG Agopian, MS Auerbach… - Journal of Nuclear …, 2009 - Soc Nuclear Med
Successful treatment of pheochromocytoma requires accurate diagnosis and localization of
tumors. Herein, we investigated the accuracy of PET using 3,4-dihydroxy-6- 18 F-fluoro-…

[HTML][HTML] Structure-guided engineering of human thymidine kinase 2 as a positron emission tomography reporter gene for enhanced phosphorylation of non-natural …

…, SS Yaghoubi, Y Su, JT Lee, MS Auerbach… - Journal of Biological …, 2012 - ASBMB
Positron emission tomography (PET) reporter gene imaging can be used to non-invasively
monitor cell-based therapies. Therapeutic cells engineered to express a PET reporter gene (…

Incidental detection of elastofibroma dorsi with 68Ga-FAPI-46 and 18F-FDG PET/CT in a patient with esophageal cancer

…, SW French, HR Schelbert, MS Auerbach… - Clinical Nuclear …, 2021 - journals.lww.com
A 71-year-old man underwent 18 F-FDG and 68 Ga-FAPI-46 PET/CT for initial staging prior
to surgery of a squamous cell carcinoma of the lower esophagus under the prospective study …

Head-to-head comparison of 68Ga-PSMA-11 PET/CT and mpMRI in the detection, intra-prostatic localization, and local extension of primary prostate cancer: A single …

…, E Felker, AT Lenis, AE Sisk, S Bahri, MS Auerbach… - 2021 - ascopubs.org
193 Background: The local staging of prostate cancer relies on systematic or targeted
biopsies and multiparametric magnetic resonance imaging (mpMRI). The role of prostate-specific …

Do bone scans over-stage disease compared to PSMA PET? An international multicenter retrospective study with blinded independent readers.

…, R Juarez, M Hernandez Pampaloni, MS Auerbach… - 2023 - ascopubs.org
5011 Background: PSMA positron emission tomography (PET) has a higher accuracy than
computed tomography (CT) and bone scans to stage patients with prostate cancer. However, …

FDG-Avid Hürthle Cell Thyroid Adenoma

R Yu, MS Auerbach - Clinical Nuclear Medicine, 2019 - journals.lww.com
Incidental thyroid uptake is found in approximately 2.5% of patients who undergo FDG PET
for nonthyroid malignancy; approximately a third of the FDG PET thyroid incidentalomas are …

Estimating treatment coverage for people with substance use disorders: an analysis of data from the World Mental Health Surveys

…, LH Andrade, L Atwoli, RP Auerbach… - World …, 2017 - Wiley Online Library
Substance use is a major cause of disability globally. This has been recognized in the recent
United Nations Sustainable Development Goals (SDGs), in which treatment coverage for …

[HTML][HTML] Clinical Progression of a Paraganglioma Over Many Years in a Man With Congenital Heart Disease

MM McConnell, MR Kanin, MS Auerbach… - AACE Clinical Case …, 2023 - Elsevier
Background Documented symptomatic progression of a paraganglioma (PGL) over many
years is unusual. Our objective is to report a young man with such an occurrence. Case Report …

FDG-PET/CT imaging predicts histopathologic treatment responses after the initial cycle of neoadjuvant chemotherapy in high-grade soft-tissue sarcomas

MR Benz, J Czernin, MS Allen-Auerbach, WD Tap… - Clinical cancer …, 2009 - AACR
Purpose: In patients with soft-tissue sarcoma (STS), the early assessment of treatment responses
is important. Using positron emission tomography/computed tomography (PET/CT) with …

Quantitative F18‐fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign

…, SM Dry, WD Tap, MS Allen‐Auerbach… - … Journal of the …, 2010 - Wiley Online Library
BACKGROUND: Correct pretreatment classification is critical for optimizing diagnosis and
treatment of patients with peripheral nerve sheath tumors (PNSTs). The aim of this study was …